The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Molecular Templates, Inc(NASDAQ:MTEM) 
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other diseases. Its proprietary drug platform technology is engineered toxin bodies (ETBs). The company's lead drug candidate is MT...
Website: http://www.mtem.com
Founded: 2000
Full Time Employees: 228
Sector: Healthcare
Industry: Biotechnology
Molecular Templates Days Payable Outstanding ttm (DPO)
Molecular Templates Days Receivable Outstanding ttm (DSO)
Molecular Templates Days Inventory Outstanding ttm (DIO)
Molecular Templates Op Cashflow Per Share ttm
Molecular Templates Free Cashflow Per Share ttm
Molecular Templates Cash Per Share ttm
Molecular Templates P/S ratio ttm
Molecular Templates (GAAP) P/E ratio ttm
Molecular Templates P/B ratio ttm
No extra charts and metrics for this ticker.